AGENUS INC Earnings Per Share (Diluted)
AGENUS INC (AGEN) reported Earnings Per Share (Diluted) of -$0.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-07
- AGENUS INC earnings per share, diluted for the quarter ending 2026-06-30 was -$0.01.
- AGENUS INC earnings per share, diluted for the quarter ending 2026-03-31 was $1.02.
- AGENUS INC earnings per share, diluted for the quarter ending 2025-09-30 was $1.94.
- AGENUS INC earnings per share, diluted for the quarter ending 2025-06-30 was -$1.00.
- AGENUS INC earnings per share, diluted for fiscal 2025 was $0.00.
- AGENUS INC earnings per share, diluted for fiscal 2024 was -$10.59.
- AGENUS INC earnings per share, diluted for fiscal 2023 was -$13.75.
- AGENUS INC earnings per share, diluted for fiscal 2022 was -$15.64.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.01 10-Q · filed 2026-08-07 | $0.96 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | $1.02 10-Q · filed 2026-05-11 | |||||||
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 | |||||||
| 2025-09-30 | $1.94 10-Q · filed 2025-11-10 | $0.37 10-Q · filed 2025-11-10 | ||||||
| 2025-06-30 | -$1.00 10-Q · filed 2026-08-07 | -$2.03 10-Q · filed 2026-08-07 | ||||||
| 2025-03-31 | -$1.03 10-Q · filed 2026-05-11 | |||||||
| 2024-12-31 | -$10.59 10-K · filed 2026-03-16 | |||||||
| 2024-09-30 | -$3.08 10-Q · filed 2025-11-10 | -$8.65 10-Q · filed 2025-11-10 | ||||||
| 2024-06-30 | -$2.52 10-Q · filed 2025-08-11 | -$5.56 10-Q · filed 2025-08-11 | ||||||
| 2024-03-31 | -$3.04 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$13.75 10-K · filed 2026-03-16 | -$0.69 10-K · filed 2024-03-14 | ||||||
| 2023-09-30 | -$3.29 10-Q · filed 2024-11-12 | -$0.16 10-Q · filed 2023-11-09 | -$11.43 10-Q · filed 2024-11-12 | -$0.57 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$3.93 10-Q · filed 2024-08-08 | -$0.20 10-Q · filed 2023-08-08 | -$8.22 10-Q · filed 2024-08-08 | -$0.41 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | -$4.31 10-Q · filed 2024-05-07 | -$0.22 10-Q · filed 2023-05-09 | ||||||
| 2022-12-31 | -$15.64 10-K · filed 2025-03-17 | -$0.78 10-K · filed 2023-03-16 | ||||||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-09 | -$0.54 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.17 10-Q · filed 2023-08-08 | -$0.35 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | -$0.19 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | -$0.11 10-K · filed 2024-03-14 | |||||||
| 2021-09-30 | $0.72 10-Q · filed 2022-11-08 | $0.18 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | -$0.37 10-Q · filed 2022-08-09 | -$0.65 10-Q · filed 2022-08-09 | ||||||
| 2020-12-31 | -$195.52 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$475.86 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.05 10-K · filed 2023-03-16 | |||||
| 2020-09-30 | -$0.28 10-Q · filed 2021-11-09 | -$0.87 10-Q · filed 2021-11-09 | ||||||
| 2020-03-31 | -$0.31 10-Q · filed 2020-05-11 | |||||||
| 2019-12-31 | -$0.22 10-K · filed 2021-03-16 | |||||||
| 2019-09-30 | -$0.33 10-K · filed 2021-03-16 | |||||||
| 2019-06-30 | -$0.38 10-K · filed 2021-03-16 | |||||||
| 2019-03-31 | $0.12 10-K · filed 2021-03-16 | |||||||
| 2018-03-31 | -$0.53 10-Q · filed 2019-05-10 | |||||||
| 2013-03-31 | -$0.35 10-Q · filed 2013-05-10 | |||||||
| 2012-12-31 | -$0.23 10-K · filed 2013-03-18 | |||||||
| 2012-09-30 | -$0.24 10-K · filed 2013-03-18 | |||||||
| 2012-06-30 | -$0.31 10-K · filed 2013-03-18 | |||||||
| 2012-03-31 | $0.29 10-Q · filed 2013-05-10 | |||||||
| 2011-03-31 | -$0.33 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |